Clorox (NYSE:CLX) Posts Earnings Results, Beats Expectations By $0.16 EPS

Clorox (NYSE:CLX) posted its earnings results on Monday. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16, RTT News reports. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period last year, the firm posted $2.16 EPS. Clorox updated its FY 2025 guidance to 6.950-7.350 EPS.

Clorox Stock Down 7.2 %

Shares of NYSE:CLX opened at $148.29 on Wednesday. The firm has a fifty day moving average price of $162.63 and a two-hundred day moving average price of $158.67. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. Clorox has a one year low of $127.60 and a one year high of $171.37. The company has a market cap of $18.36 billion, a price-to-earnings ratio of 51.67, a PEG ratio of 2.92 and a beta of 0.42.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Barclays reduced their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Wells Fargo & Company upped their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Clorox has an average rating of “Hold” and an average target price of $157.64.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.